GlobalDeal

Baxalta

Biotechnology · Bannockburn, United States

baxalta.com

About Baxalta

Baxalta Incorporated was a global biopharmaceutical company that focused on developing and delivering innovative therapies for people with hemophilia, immune deficiencies, and other chronic and rare diseases. Founded in 2015 as a spin-off from Baxter International, Baxalta specialized in biologics and was known for its commitment to patient care and research. The company was headquartered in Bannockburn, Illinois, and operated in over 100 countries. In 2016, Baxalta was acquired by Takeda Pharmaceutical Company Limited, further expanding its reach and capabilities in the biopharmaceutical sector. The company was recognized for its strong pipeline of therapies and its dedication to improving the lives of patients worldwide.

Company facts

Industry
Biotechnology
Sub-industries
Biopharmaceuticals, Hemophilia Treatments, Immune Deficiency Therapies, Chronic Disease Management, Rare Disease Treatments
Location
Bannockburn, United States
Employees
5K–10K
Founded
2015

Products and services

Open Baxalta in GlobalDeal Is this your company? Update the details for free

More Biotechnology companies in United States

All 17,138 Biotechnology companies in United States →